When compared to daily oral treatment, British pharmaceutical company GSK said on Wednesday that its long-acting injectable HIV medicine has shown promise in suppressing the viral load of infected individuals,…

The FDA has approved a treatment protocol for a particular type of lung cancer that combines chemotherapy and AstraZeneca’s popular cancer medicine Tagrisso, according to an announcement by the firm…

On Friday, global pharmaceutical giant Sanofi announced it had received an approval for its new treatment for sleeping sickness, called rhodesiense, from the European Medicines Agency (EMA). In the announcement,…

On Sunday, the Financial Times reported that AstraZenica, the Anglo-Swedish drugmaker, has linked up with US artificial intelligence (AI) biologics firm Absci, in a deal worth $247 million, which will…

On Wednesday, Bayer announced that it was exploring splitting off either the diversified group’s Consumer Health or Crop Science divisions, however it ruled out performing a three-way split. In a…

On Tuesday, the US Food and Drug Administration (FDA) announced that it has accepted AstraZeneca’s application seeking approval to sell a new nasal flu vaccine which will allow patients and…

On Monday, Roche announced it would be buying Televant, a biotechnology firm which has developed a new treatment for inflammatory bowel diseases. The firm will be sold for an initial…

On Thursday, Eli Lilly said it was suing 11 online pharmacies in an effort to prevent them from importing, selling, or distributing products which claimed to contain Mounjaro, the active…

On Wednesday, Belgium-based Hyloris Pharmaceuticals announced that the US Food and Drug Administration (FDA) has approved its drug for post-operative pain, adding the drug is expected to hit the market…

Due to flagging demand for its Covid products this year, Pfizer has been forced to slash its full-year earnings and revenue guidance on Friday. The company downgraded its guidance, saying…